SAN DIEGO--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation (NYSEMKT:APHB), a global leader in the development of bacteriophage-based antibacterial therapies to treat drug-resistant infections, today announced that it will report financial results for the quarter ended March 31, 2016 on Thursday, May 12. AmpliPhi management will host a conference call at 8:30 a.m. Eastern Time on May 13, 2016 to review financial results and provide a corporate update.
To access the call, dial 844-745-6357 (US) or 661-378-9813 (outside of the US). The passcode is 10677209. A live webcast will be available in the Events and Presentations section of the Investor Relations page at ampliphibio.com/events-and-presentations. Please log in approximately 10 minutes prior to the scheduled start time.
To access the call, dial 844-745-6357 (US) or 661-378-9813 (outside of the US). The passcode is 10677209. A live webcast will be available in the Events and Presentations section of the Investor Relations page at ampliphibio.com/events-and-presentations. Please log in approximately 10 minutes prior to the scheduled start time.
